Figure 3.
Effects of Lenalidomide on anti-dsDNA antibody and complement levels. Comparison of anti-dsDNA antibody titres (A) and complement levels (B) at baseline and after completing the course of treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.